Essential fatty acids: Biochemistry, physiology and pathology

被引：490

作者：

UND Life Sciences, Shaker Heights, OH, United States ^{[1
]}

机构：

[1] UND Life Sciences, Shaker Heights, OH

来源：

Biotechnol. J. | 2006年 / 4卷 / 420-439期

关键词：

Alpha/gamma-linolenic acid; Arachidonic acid; Eicosapentaenoic acid; Essential fatty acids; Linoleic acid;

D O I：

10.1002/biot.200600012

中图分类号：

学科分类号：

摘要：

Essential fatty acids (EFAs), linoleic acid (LA), and αlinolenic acid (ALA) are essential for humans, and are freely available in the diet. Hence, EFA deficiency is extremely rare in humans. To derive the full benefits of EFAs, they need to be metabolized to their respective long-chain metabolites, i.e., dihomo-γ-linolenic acid (DGLA), and arachidonic acid (AA) from LA; and eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from ALA. Some of these long-chain metabolites not only form precursors to respective prostaglandins (PGs), thromboxanes (TXs), and leukotrienes (LTs), but also give rise to lipoxins (LXs) and resolvins that have potent anti-inflammatory actions. Furthermore, EFAs and their metabolites may function as endogenous angiotensin-converting enzyme and 3-hdroxy-3-methylglutaryl coenzyme A reductase inhibitors, nitric oxide (NO) enhancers, anti-hypertensives, and anti-atherosclerotic molecules. Recent studies revealed that EFAs react with NO to yield respective nitroalkene derivatives that exert cell-signaling actions via ligation and activation of peroxisome proliferator-activated receptors. The metabolism of EFAs is altered in several diseases such as obesity, hypertension, diabetes mellitus, coronary heart disease, schizophrenia, Alzheimer's disease, atherosclerosis, and cancer. Thus, EFAs and their derivatives have varied biological actions and seem to be involved in several physiological and pathological processes. © 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

引用

页码：420 / 439

页数：19

共 163 条

[101]

DeLuca P., Rossetti R.G., Alavian C., Karim P., Zurier R.B., Effects of gammalinolenic acid on interleukin-1 beta and tumor necrosis factor-alpha secretion by stimulated human peripheral blood monocytes: studies in vitro and in vivo, J. Invest. Med., 47, pp. 246-250, (1999)

[102]

Mancuso P., Whelan J., DeMichele S.J., Snider C.C., Et al., Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats, Crit. Care Med., 25, pp. 1198-1206, (1997)

[103]

Palombo J.D., DeMichele S.J., Boyce P.J., Lydon E.E., Et al., Effect of short-term enteral feeding with eicosapentaenoic and gammalinolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats, Crit. Care Med., 27, pp. 1908-1915, (1999)

[104]

Barham J.B., Edens M.B., Fonteh A.N., Johnson M.M., Et al., Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans, J. Nutr., 130, pp. 1925-1931, (2000)

[105]

Thies F., Miles E.A., Nebe-von-Caron G., Powell J.R., Et al., Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults, Lipids, 36, pp. 1183-1193, (2001)

[106]

Lo C.J., Chiu K.C., Fu M., Lo R., Helton S., Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity, J. Surg., 82, pp. 216-221, (1999)

[107]

Kambe T., Murakami M., Kudo I., Polyunsaturated fatty acids potentiate interleukin-1-stimulated arachidonic acid release by cells overexpressing type IIA secretory phospholipase A2, FEBS Lett, 453, pp. 81-84, (1999)

[108]

Gilroy D.W., Newson J., Sawmynaden P., Willoughby D.A., Croxtall J.D., A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation, FASEB J, 18, pp. 489-498, (2004)

[109]

Borghaei H., Borghaei R.C., Ni X., Pease E., Et al., Evidence that suppression of IL-1 induced collagenase mRNA expression by dihomo-gamma-linolenic acid (DGLA) involves inhibition of NF kappa B binding, Inflamm. Res., SUPPL. 46, (1997)

[110]

Zhao Y., Joshi-Barve S., Barve S., Chen L.H., Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation, J. Am. Coll. Nutr., 23, pp. 71-78, (2004)

← 6 7 8 9 10 11 12 13 14 15 →